AMY JUSTICE: Open Payments
NPI 1922833581 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,985 in 208 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,184 · 2025 $3,985
Food & beverage: $3,901Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $658 |
| ABBVIE INC. | 37 | $648 |
| Takeda Pharmaceuticals U.S.A., Inc. | 34 | $623 |
| Aimmune Therapeutics, Inc. | 33 | $528 |
| Madrigal Pharmaceuticals | 20 | $307 |
| Ipsen Biopharmaceuticals, Inc | 12 | $207 |
| Phathom Pharmaceuticals, Inc. | 9 | $202 |
| Janssen Scientific Affairs, LLC | 2 | $190 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $177 |
| Regeneron Healthcare Solutions, Inc. | 6 | $113 |
Products named: TREMFYA, ENTYVIO, RINVOQ, REZDIFFRA, ZENPEP, VOWST, IQIRVO, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
